{"id":15828,"name":"Novartis Venture Fund","slug":"novartis-venture-fund","website":"https://www.nvfund.com/","hqGeo":"Europe, United States","stageFocus":["Seed","Series A"],"sectorTags":["Healthcare","EdTech"],"excludedSectors":[],"checkSizeMin":2000000,"checkSizeMax":15000000,"thesisSummary":"Invests in innovative life science companies in biotechnology and biopharmaceuticals addressing unmet patient needs. Best for science-heavy biotech, though the check size may be above the lower end of the target range.","thesisNarrative":null,"logoUrl":null,"aumUsd":1000000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Epi Biologics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops targeted protein degradation therapies.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Epsilogen","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops IgE antibody therapies for cancer.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Fore Biotherapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops precision oncology therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Salvina","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapeutics in life sciences.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ablation Frontiers","companyUrl":null,"stage":"Historical exit; investment date not stated","sector":"Medtech / cardiology","investmentYear":null,"description":"Medical device company focused on cardiac ablation technologies.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Adenosine Therapeutics","companyUrl":null,"stage":"Historical exit; investment date not stated","sector":"Biopharma","investmentYear":null,"description":"Biopharma company focused on adenosine-pathway therapies.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Arctos Medical","companyUrl":null,"stage":"Historical exit; investment date not stated","sector":"Medtech","investmentYear":null,"description":"Medical device company later acquired by Novartis.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Amphista Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops targeted protein degradation therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Anaveon","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops immunotherapy candidates for cancer and immune-related diseases.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aravax","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops peptide-based therapies for food allergies.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Artios Pharma Limited","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops DDR-targeting cancer therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Atalanta","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops RNAi-based therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Averna Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops novel therapeutics for genetic disease.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ONL Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapies to preserve vision and treat eye disease.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Enterprise Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops treatments for respiratory diseases.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"FoRx Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops oncology therapies.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"HYKU Biosciences","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapeutic platforms in biotech.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"LoQus23","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapies for neurodegenerative diseases.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Mediar Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapies targeting fibrosis and inflammatory disease.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NRG Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops treatments for neurodegenerative disease.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"RhyGaze","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops gene therapies for inherited retinal disease.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"SpliceBio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops gene therapy approaches based on protein splicing.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Tagworks Pharmaceuticals","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops precision therapy for severe diseases including cancer.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"GentiBio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops engineered T-regulatory cell therapies.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Granite Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops immunology-focused biologics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Protego","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops precision medicines for immune disorders.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Vivet Therapeutics SAS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops gene therapies for rare diseases.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Arvada Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapies for inflammatory and immune diseases.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"AstronauTx","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapies for neurodegenerative disease.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CatalYm","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops immunotherapies that modulate the tumor microenvironment.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Citryll","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapies targeting NETosis in inflammatory disease.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Kynexis","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops KYN-5356 for cognitive impairment associated with schizophrenia.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Seawolf","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops biotech therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Sidewinder Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapeutics for difficult-to-treat diseases; a funding item references Novartis Venture Fund as a supporter.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Alesta Therapeutics","companyUrl":null,"stage":"Historical exit; investment date not stated","sector":"Biopharma","investmentYear":null,"description":"Biopharma company later acquired by BioMarin.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Capstan Therapeutics","companyUrl":null,"stage":"Historical exit; investment date not stated","sector":"Cell therapy","investmentYear":null,"description":"Cell therapy company later acquired by AbbVie.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Immunitas","companyUrl":null,"stage":"Historical exit; investment date not stated","sector":"Immunology","investmentYear":null,"description":"Immunology company that licensed a preclinical program to Boehringer Ingelheim.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":1,"partners":[{"id":51642,"name":"Unknown","title":"Partner","seniority":null,"focusTags":["Biotech","Biopharma"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[{"id":1029,"name":"Novartis Venture Fund III","vintageYear":2021,"sizeUsd":200000000,"status":"actively investing","focusAreas":[]},{"id":1028,"name":"Novartis Venture Fund II","vintageYear":2016,"sizeUsd":150000000,"status":"actively investing","focusAreas":[]},{"id":1027,"name":"Novartis Venture Fund","vintageYear":2011,"sizeUsd":100000000,"status":"actively investing","focusAreas":[]}],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[{"kind":"fund","title":"Raised Novartis Venture Fund III ($200M)","url":null,"source":"fund records","occurredAt":"2021-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Novartis Venture Fund II ($150M)","url":null,"source":"fund records","occurredAt":"2016-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Novartis Venture Fund ($100M)","url":null,"source":"fund records","occurredAt":"2011-06-30T00:00:00.000Z"}],"contentUpdatedAt":"2026-10-27T01:34:30.363Z","investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"},{"id":2457,"name":"Equilibrium Ventures","slug":"equilibrium-ventures","logoUrl":null,"website":"https://equilibrium.co/","stageFocus":["Seed"],"sectorTags":["Developer Tools","Healthcare"],"hqGeo":"Portland, OR"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"investormatch-mcp-server-claude-chatgpt","title":"Your Investor List Now Lives Inside Claude and ChatGPT"},{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-25T15:29:01.377Z"}